The Regents of the University of California;Horizon Orphan LLC
发明人:
Ranjan Dohil,Patrice Rioux
申请号：
US15771947
公开号：
US20180338928A1
申请日:
2016.11.16
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The disclosure relates, in general, to treatment of fatty liver disorders comprising administering compositions comprising cysteamine or cystamine compositions. The disclosure provides administration of enterically coated cysteamine compositions to treat fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
